Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network

BACKGROUND: Duchenne muscular dystrophy (DMD) is the most commonly inherited neuromuscular disease. Therapeutic agents for the treatment of rare disease, namely “orphan drugs”, have recently drawn the attention of researchers and pharmaceutical companies. To ensure the successful conduction of clini...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Health Serv Res
Main Authors: Shimizu, Reiko, Ogata, Katsuhisa, Tamaura, Akemi, Kimura, En, Ohata, Maki, Takeshita, Eri, Nakamura, Harumasa, Takeda, Shin’ichi, Komaki, Hirofumi
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Technical Advance
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4939632/
https://ncbi.nlm.nih.gov/pubmed/27401940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-016-1477-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares